SBS stock highlights Sabesp's EMAE merger deadline

SBS stock is tied to Sabesp's completed EMAE merger approval, with each eligible EMAE share converting into 1.3195 Sabesp common shares. StockTitan reported the terms from the September 16, 2026 corporate filing, including an October 19, 2026 deadline for eligible dissenting EMAE holders.

EMAE terms set a clear deadline

The merger transfers EMAE's remaining shareholder base into Sabesp and leaves Sabesp investors without withdrawal rights. Eligible EMAE dissenters can instead request BRL 18.18 per share, based on book value at June 30, 2026, while the exchange ratio gives them 1.3195 Sabesp shares for each EMAE share.

The structure creates two different outcomes for EMAE holders: equity participation through the share exchange or cash reimbursement through the withdrawal process. Ativo Virtual said the approval occurred on September 16, 2026, and that the reimbursement amount used the June 30, 2026 book value.

Revenue grows while profit falls

Sabesp's second-quarter operating picture was mixed. According to Money Times on September 8, 2026, net revenue reached BRL 10.2 billion in Q2 2026, up 13.9 percent from the prior year, while net income fell 31.4 percent to BRL 1.46 billion. The company invested BRL 7.5 billion in the first half, a 15.6 percent annual increase.

That comparison explains why the merger is only one part of the SBS investment case. Revenue expansion and higher capital spending support Sabesp's universalization program, but the 31.4 percent profit decline shows the near-term cost of that investment cycle.

SBS market value and listing

SBS had a market capitalization of USD 17.7 billion as of September 29, 2026. The 52-week range was USD 4.43 to USD 7.16, placing the company in a broad trading band while the merger timetable moves toward its October 19 deadline.

More news and analysis on SBS stock